Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Willem Joost Wiersinga

Showing results (1-10 of 19) with videos related to

Pageof 2
Sort By:
Current Infectious Disease Reports|September 21, 2007
Is the septic response good or bad?Willem Joost Wiersinga, Tom van der Poll
Critical Care (London, England)|March 21, 2023
Host Response Biomarkers for Sepsis in the Emergency RoomOren Turgman, Michiel Schinkel, Willem Joost Wiersinga
Critical Care (London, England)|March 22, 2018
The emerging role of the microbiota in the ICUNora Suzanne Wolff, Floor Hugenholtz, Willem Joost Wiersinga
Antibiotics (Basel, Switzerland)|February 25, 2022
Probiotics in the Intensive Care UnitAlex R Schuurman, Robert F J Kullberg, Willem Joost Wiersinga
Expert Review of Anti-Infective Therapy|June 26, 2014
The coagulation system in melioidosis: from pathogenesis to new treatment strategiesLiesbeth Martine Kager, Tom van der Poll, Willem Joost Wiersinga
Journal of Leukocyte Biology|November 23, 2007
Inflammation, endothelium, and coagulation in sepsisMarcel Schouten, Willem Joost Wiersinga, Marcel Levi, et al.
Journal of Innate Immunity|June 10, 2010
The systemic pro-inflammatory response in sepsisHanna Katrien de Jong, Tom van der Poll, Willem Joost Wiersinga
Virulence|June 19, 2013
Host innate immune responses to sepsisWillem Joost Wiersinga, Stije J Leopold, Duncan R Cranendonk, et al.
Scientific Reports|February 11, 2022
Mortality and readmission rates among hospitalized COVID-19 patients with varying stages of chronic kidney disease: a multicenter retrospective cohortBrent Appelman, Jetta J Oppelaar, Lani Broeders, et al.
Critical Care Clinics|November 19, 2017
Biomarkers in SepsisTjitske S R van Engelen, Willem Joost Wiersinga, Brendon P Scicluna, et al.
Pageof 2

Showing results (1-10 of 19) with videos related to

Sort By:
Pageof 2
Current Infectious Disease Reports|September 21, 2007
Is the septic response good or bad?Willem Joost Wiersinga, Tom van der Poll
Critical Care (London, England)|March 21, 2023
Host Response Biomarkers for Sepsis in the Emergency RoomOren Turgman, Michiel Schinkel, Willem Joost Wiersinga
Critical Care (London, England)|March 22, 2018
The emerging role of the microbiota in the ICUNora Suzanne Wolff, Floor Hugenholtz, Willem Joost Wiersinga
Antibiotics (Basel, Switzerland)|February 25, 2022
Probiotics in the Intensive Care UnitAlex R Schuurman, Robert F J Kullberg, Willem Joost Wiersinga
Expert Review of Anti-Infective Therapy|June 26, 2014
The coagulation system in melioidosis: from pathogenesis to new treatment strategiesLiesbeth Martine Kager, Tom van der Poll, Willem Joost Wiersinga
Journal of Leukocyte Biology|November 23, 2007
Inflammation, endothelium, and coagulation in sepsisMarcel Schouten, Willem Joost Wiersinga, Marcel Levi, et al.
Journal of Innate Immunity|June 10, 2010
The systemic pro-inflammatory response in sepsisHanna Katrien de Jong, Tom van der Poll, Willem Joost Wiersinga
Virulence|June 19, 2013
Host innate immune responses to sepsisWillem Joost Wiersinga, Stije J Leopold, Duncan R Cranendonk, et al.
Scientific Reports|February 11, 2022
Mortality and readmission rates among hospitalized COVID-19 patients with varying stages of chronic kidney disease: a multicenter retrospective cohortBrent Appelman, Jetta J Oppelaar, Lani Broeders, et al.
Critical Care Clinics|November 19, 2017
Biomarkers in SepsisTjitske S R van Engelen, Willem Joost Wiersinga, Brendon P Scicluna, et al.
Pageof 2